{"disease":{"id":"hemochromatosis","name":"hemochromatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00007150","title":"Treatment of Hemochromatosis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":622,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT00001203","title":"Deferoxamine for the Treatment of Hemochromatosis","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05742035","title":"Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Interregionale Blutspende SRK","has_results":false},{"nct_id":"NCT04006249","title":"Haemochromatosis and Periodontitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT07332091","title":"Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT03395704","title":"A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"La Jolla Pharmaceutical Company","has_results":true},{"nct_id":"NCT00068159","title":"Cardiac Function in Patients With Hereditary Hemochromatosis","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT02099214","title":"Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04631718","title":"MRI QSM Imaging for Iron Overload","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT06137079","title":"\"Iron Overload and Endocrinological Diseases\"","phase":"","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria di Modena","has_results":false},{"nct_id":"NCT01949467","title":"Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT03743272","title":"Repeatability and Reproducibility of Multiparametric MRI","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT03203850","title":"Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":45,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03453918","title":"Effects of Polyphenols on Iron Absorption in Iron Overload Disorders.","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03654794","title":"Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT05238207","title":"A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Bond Biosciences","has_results":false},{"nct_id":"NCT02263638","title":"Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04202965","title":"PTG-300 in Subjects With Hereditary Hemochromatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Protagonist Therapeutics, Inc.","has_results":true},{"nct_id":"NCT01810965","title":"Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT00712738","title":"Oral Nifedipine to Treat Iron Overload","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}